Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2014
Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cellsAnat Globerson-Levin, Tova Waks, Zelig Eshhar
European Journal of Immunology|July 1, 2021
CAR T cells: Building on the CD19 paradigmAnat Globerson Levin, Isabelle Rivière, Zelig Eshhar, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2020
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approachAnat Globerson Levin, Natalie Kronik, Tamar Shiloach, et al.
Cells|September 28, 2023
Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector FunctionsJulia Sajman, Oren Yakovian, Naamit Unger Deshet, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 10, 2025
Volumetric Nanodroplet-Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy PlatformBar Glickstein, Mike Bismuth, Roni Gattegno, et al.
Human Gene Therapy|September 8, 2021
Extracellular Vesicles Derived from Chimeric Antigen Receptor-T Cells: A Potential Therapy for CancerAnat Aharon, Galit Horn, Tali Hana Bar-Lev, et al.
Nature Communications|June 15, 2021
P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomasLiat Rousso-Noori, Ignacio Mastandrea, Shauli Talmor, et al.
Frontiers in Oncology|May 31, 2021
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric FieldsGil Diamant, Hadar Simchony Goldman, Lital Gasri Plotnitsky, et al.
Pageof 2